Skip to main content
    N

    Neumora Therapeutics, Inc. (NMRA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.33
    -0.04 (-9.47%)

    Market Cap: $69.43M

    Last updated: Nov 17, 2026 at 4:17 PM ET

    Neumora Therapeutics, Inc. (NMRA) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Neumora Therapeutics (NMRA) has a latest price of $0.33 on Nov 17, 2026, 90.8% below its 52-week high of $3.65. Its price fell 87.4% over the past 12 months. The month-end price fell 96.6% over the 3 years through Oct 2026, a compound annual decline of 67.7%.

    Price Chart

    From Sep 2023 to Oct 2026, its highest month-end close was $17.63 in Feb 2024 and its lowest $0.37 in Oct 2026, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart NMRA with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NMRA.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 79.6%, and over 6 months it fell 80.0%.

    PeriodChange
    1 month-28.8%
    3 months-79.6%
    6 months-80.0%
    12 months-87.4%
    12 months, with dividends-87.4%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years-96.6%-67.7%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2024, when the price fell 37.8%, and its weakest was 2025, when it fell 83.1%.

    YearCloseChange
    2026 through Oct 2026$0.37-79.5%
    2025$1.79-83.1%
    2024$10.60-37.8%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 40.7% below its 50-day average of $0.56 and 80.2% below its 200-day average of $1.69.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$0.33
    52-week high$3.65-90.8%
    52-week low$0.32+6.2%
    50-day average$0.56-40.7%
    200-day average$1.69-80.2%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 98.3%.

    MeasureValue
    1-year beta0.74
    Largest fall, 1 year-90.7%
    Largest fall, 3 years-98.3%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About NMRA

    What is NMRA's 1-year price change?

    Neumora Therapeutics's price fell 87.4% over the past 12 months. With dividends included, the 12-month total return was -87.4%.

    How has NMRA stock done over the long term?

    Neumora Therapeutics's month-end price fell 96.6% over the 3 years through Oct 2026, a compound annual decline of 67.7%. These figures leave out dividends.

    What is NMRA's 52-week high and low?

    Neumora Therapeutics's 52-week high is $3.65 and its 52-week low is $0.32. Its latest price of $0.33 on Nov 17, 2026 is 90.8% below the high.

    What is NMRA's beta?

    Neumora Therapeutics's 1-year beta against the S&P 500 is 0.74, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 90.7%.

    Is the NMRA chart free?

    Yes. Advanced Charting for NMRA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.